HCL Technologies (HCL), a leading global IT services provider, has been chosen by the Blue Cross and Blue Shield Association (BCBSA) to be part of a national purchasing arrangement for the ICD-10 transition. With the help of this arrangement, HCL’s products and service capabilities will be available to the 39 independent Blue Cross and Blue Shield companies across the country.
The ICD transition is one of the many paradigms of the healthcare industry that is changing in the complicated processes of healthcare reform. The transition to ICD-10 (the 10th revision of coding put out by the International Statistical Classification of Diseases and Related Health Problems) goes into effect in October, 2013. This unfunded mandate will put heavy financial and operational burdens on payer organizations and impact Payers ability to accurately process and pay claims.
HCL’s iCRM tool allows payer organizations to deal with the revision from ICD-9 to ICD-10. iCRM can be integrated with any Payer application or system. It addresses all types of integration and data handling with respect to real time, batch and user queries. In addition, HCL’s iDataPrepare and iCompare for ICD testing and PRIZM solution for project management have unique functionalities to aid the remediation processes as well.
HCL is a $5.9 billion leading global technology and IT enterprise comprising two companies listed in India -HCL Technologies and HCL Infosystems. A pioneer of modern computing, HCL is a global transformational enterprise today. Its range of offerings includes product engineering, custom & package applications, BPO, IT infrastructure services, IT hardware, systems integration, and distribution of information and communications technology (ICT) products across a wide range of focused industry verticals.
| Company Name | CMP |
|---|---|
| TCS | 4348.20 |
| Infosys | 1978.90 |
| HCL Tech. | 1959.20 |
| Wipro | 312.65 |
| Tech Mahindra | 1778.30 |
| View more.. | |
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Make an informed decision for Stocks
Invest using an intelligent system with powerful data-driven tools that help you identify opportunities and make informed buy-hold-sell decisions
Buy quality Stocks when they are available at reasonable prices and supported by an upward price trend and Sell when they are Overvalued using the Decizen Rating System. Covers 3500+ stocks
Limited to the first 10 users today!
Practical Stock Investing Hand Book
By - Raymond Moses
Founder of MoneyWorks4Me | Consultant | Trainer | Author | TEDx Speaker
Register & Get Instant Access!Don't miss out! First 10 users today get it FREE
With this 4 hrs Masterclass, you’ll be able to:
Download APP
